ARCHIVES

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

In Brief: Budget Timetable Puts Pressure On Congress To Complete Appropriations Before Oct. 1

January 30, 1976

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005